SCHEMBL4923143

SCHEMBL4923143

COc1ccc(-c2cccc3c(N)c4c(nc23)CN(C)C4=O)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGDS O60760 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ HRH4 Q9H3N8 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ GUSB P08236 1/20 0.36
▸ BACE1 P56817 1/20 0.36
▸ PRMT1 Q99873 1/20 0.36
▸ ACACA Q13085 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4924170 0.88 TP53 (0.42) ALDH1A1HPGDSGAAMAPTL3MBTL1
SCHEMBL2656333 0.87 PDE5A (0.44) ALDH1A1HPGDSGAAMAPTL3MBTL1
SCHEMBL4925336 0.85 HRH4 (0.40) ALDH1A1KDM4EHRH4HPGDADORA1
SCHEMBL2662174 0.85 GABRG2 (0.46) GAANPC1PRMT1PDE10A
SCHEMBL2656734 0.84 BACE1 (0.38) ALDH1A1MAPTMEN1KMT2AADORA1
SCHEMBL4916340 0.83 CRHR1 (0.44) ALDH1A1GAAMEN1KMT2AKDM4E
SCHEMBL2661358 0.82 PDE5A (0.40) ALDH1A1L3MBTL1MEN1KMT2AKDM4E
SCHEMBL2660620 0.82 GABRG2 (0.41) KMT2AKDM4EHRH4
SCHEMBL2655674 0.82 GABRA1 (0.46) ALDH1A1MAPTMEN1KMT2AADORA2A
SCHEMBL4921019 0.81 HRH4 (0.37) HRH4NPC1ADORA1BACE1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US claimed
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318943-A1 Compounds and Uses Thereof - 848 COMT, BACE1, BDNF ALDH1A1 442/4885HPGDS 4632/4885GAA 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback